...
首页> 外文期刊>Journal of Surgical Research: Clinical and Laboratory Investigation >Effects of combination dobutamine and vasopressin therapy on microcirculatory blood flow in a porcine model of severe endotoxic shock.
【24h】

Effects of combination dobutamine and vasopressin therapy on microcirculatory blood flow in a porcine model of severe endotoxic shock.

机译:多巴酚丁胺和血管加压素联合治疗对严重内毒素性休克猪模型微循环血流的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Dobutamine (DB) has been recommended in combination with vasopressor therapy in septic shock, given its reported ability to improve mesenteric and microcirculatory perfusion. Vasopressin (VP) is typically reserved as a second-line agent due to the concern of ischemia. The purpose of our study was to determine whether combination DB and VP therapy improved microcirculatory blood flow in severe endotoxic shock. METHODS: Septic shock was induced in 20 anesthetized piglets with injection of E. coli endotoxin. DB (10 mug/kg/min, n = 5) and VP (0.04 units/min, n = 10) were administered alone and in combination (n = 15). Measurements were compared at baseline, following endotoxin administration, and following treatment. Microcirculatory blood flow was determined via the injection of colored microspheres. RESULTS: VP completely reversed endotoxin-mediated hypotension with a mean arterial pressure (MAP) of 85 +/- 4.5 mm Hg, which was not significantly altered with the addition of DB (77 +/- 4.9 mm Hg). Endotoxin uniformly depressed cardiac output (CO) from baseline (227 +/- 10.7 versus 174 +/- 12.4 mL/min/kg) despite treatment with VP alone or in combination with DB. The addition of DB did not improve the CO in this severe septic shock model. VP was found to shunt microcirculatory flow from the skin and GI tract to vital organs such as the brain, liver, and kidneys, which was not altered with the addition of DB. CONCLUSIONS: Results indicate that DB is ineffective in increasing CO or improving mesenteric blood flow when used with physiologic replacement doses of VP. In combination, DB is unable to overcome the blood flow distribution achieved with VP administration alone in severe endotoxic shock.
机译:背景:鉴于已报道多巴酚丁胺(DB)具有改善肠系膜和微循环灌注的能力,因此已建议在脓毒性休克中与血管加压药联合使用。由于担心缺血,通常将加压素(VP)保留为二线药物。我们研究的目的是确定DB和VP联合治疗是否可改善严重内毒素性休克中的微循环血流量。方法:在20只麻醉的仔猪中注射大肠杆菌内毒素引起败血性休克。 DB(10杯/公斤/分钟,n = 5)和VP(0.04单位/分钟,n = 10)分别和联合给药(n = 15)。在基线,内毒素给药后和治疗后比较测量值。通过注射彩色微球确定微循环血流量。结果:VP完全逆转了内毒素介导的低血压,平均动脉压(MAP)为85 +/- 4.5 mm Hg,添加DB(77 +/- 4.9 mm Hg)并没有明显改变。尽管单独使用VP或与DB联合治疗,内毒素仍较基线均匀降低了心输出量(CO)(227 +/- 10.7对174 +/- 12.4 mL / min / kg)。在这种严重的脓毒性休克模型中,添加DB并不能改善CO。发现VP可以使皮肤和胃肠道的微循环血流分流至大脑,肝脏和肾脏等重要器官,而添加DB并不会改变这种循环。结论:结果表明,当与生理替代剂量的VP一起使用时,DB在增加CO或改善肠系膜血流方面无效。总之,在严重的内毒素休克中,DB无法克服单独使用VP所获得的血流分布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号